AI MARKET SCANNING

Innoviva, Inc.

📅 Next Catalyst: Nov 04, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +1.76%
MAX GAP RECORD +9.03%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $INVA
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (UNDETERMINED) 🔮 UPCOMING 🔒
Aug 05, 2026 Earnings Release 2026-08-05 (AFTER CLOSE)
+3.02%
May 06, 2026 Earnings Release 2026-05-06 (AFTER CLOSE)
+4.31%
Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE)
+3.14%
Nov 05, 2025 Earnings Release 2025-11-05 (AFTER CLOSE)
+8.89%
Aug 06, 2025 Earnings Release 2025-08-06 (AFTER CLOSE)
+0.05%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
+0.78%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
-0.15%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.7%
Bullish Gaps (6)
Bearish Gaps (1)
Neutral / Flat (7)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $INVA

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Innoviva, Inc. operates as a biopharmaceutical company in the United States and internationally. Its royalty portfolio includes RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol, and an inhaled corticosteroid, and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, and ABA, VI….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗